365 related articles for article (PubMed ID: 38779674)
21. Gut microbial metabolite TMAO increases peritoneal inflammation and peritonitis risk in peritoneal dialysis patients.
Zhang L; Xie F; Tang H; Zhang X; Hu J; Zhong X; Gong N; Lai Y; Zhou M; Tian J; Zhou Z; Xie L; Hu Z; Zhu F; Jiang J; Nie J
Transl Res; 2022 Feb; 240():50-63. PubMed ID: 34673277
[TBL] [Abstract][Full Text] [Related]
22. Inflammation in peritoneal dialysis.
Lai KN; Leung JC
Nephron Clin Pract; 2010; 116(1):c11-8. PubMed ID: 20460934
[TBL] [Abstract][Full Text] [Related]
23. IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis.
Marchant V; Tejera-Muñoz A; Marquez-Expósito L; Rayego-Mateos S; Rodrigues-Diez RR; Tejedor L; Santos-Sanchez L; Egido J; Ortiz A; Valdivielso JM; Fraser DJ; López-Cabrera M; Selgas R; Ruiz-Ortega M
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32987705
[TBL] [Abstract][Full Text] [Related]
24. Peritoneal macrophage heterogeneity is associated with different peritoneal dialysis outcomes.
Liao CT; Andrews R; Wallace LE; Khan MW; Kift-Morgan A; Topley N; Fraser DJ; Taylor PR
Kidney Int; 2017 May; 91(5):1088-1103. PubMed ID: 28065517
[TBL] [Abstract][Full Text] [Related]
25. [Selected indices of peritoneal fibrosis in patients undergoing peritoneal dialysis].
Penar J; Weyde W; Krajewska M; Madziarska K; Gołebiowski T; Szymczak M; Kłak R; Klinger M
Postepy Hig Med Dosw (Online); 2009 Apr; 63():200-4. PubMed ID: 19502680
[TBL] [Abstract][Full Text] [Related]
26. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients.
Zhou Q; Bajo MA; Del Peso G; Yu X; Selgas R
Kidney Int; 2016 Sep; 90(3):515-24. PubMed ID: 27282936
[TBL] [Abstract][Full Text] [Related]
27. Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells.
Yung S; Chan TM
Mediators Inflamm; 2012; 2012():484167. PubMed ID: 22577250
[TBL] [Abstract][Full Text] [Related]
28. Peritoneal Membrane Preservation.
Bajo MA; Del Peso G; Teitelbaum I
Semin Nephrol; 2017 Jan; 37(1):77-92. PubMed ID: 28153197
[TBL] [Abstract][Full Text] [Related]
29. T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage.
Liappas G; Gónzalez-Mateo GT; Majano P; Sánchez-Tomero JA; Ruiz-Ortega M; Rodrigues Díez R; Martín P; Sanchez-Díaz R; Selgas R; López-Cabrera M; Aguilera Peralta A
Biomed Res Int; 2015; 2015():416480. PubMed ID: 26064907
[TBL] [Abstract][Full Text] [Related]
30. Pathophysiology of the peritoneal membrane during peritoneal dialysis: the role of hyaluronan.
Yung S; Chan TM
J Biomed Biotechnol; 2011; 2011():180594. PubMed ID: 22203782
[TBL] [Abstract][Full Text] [Related]
31. Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.
Schaefer B; Bartosova M; Macher-Goeppinger S; Sallay P; Vörös P; Ranchin B; Vondrak K; Ariceta G; Zaloszyc A; Bayazit AK; Querfeld U; Cerkauskiene R; Testa S; Taylan C; VandeWalle J; Yap Y; Krmar RT; Büscher R; Mühlig AK; Drozdz D; Caliskan S; Lasitschka F; Fathallah-Shaykh S; Verrina E; Klaus G; Arbeiter K; Bhayadia R; Melk A; Romero P; Warady BA; Schaefer F; Ujszaszi A; Schmitt CP
Kidney Int; 2018 Aug; 94(2):419-429. PubMed ID: 29776755
[TBL] [Abstract][Full Text] [Related]
32. Mesothelial cell transplantation in models of acute inflammation and chronic peritoneal dialysis.
Hekking LH; Harvey VS; Havenith CE; van den Born J; Beelen RH; Jackman RW; Nagy JA
Perit Dial Int; 2003; 23(4):323-30. PubMed ID: 12968839
[TBL] [Abstract][Full Text] [Related]
33. New developments in peritoneal fibroblast biology: implications for inflammation and fibrosis in peritoneal dialysis.
Witowski J; Kawka E; Rudolf A; Jörres A
Biomed Res Int; 2015; 2015():134708. PubMed ID: 26495280
[TBL] [Abstract][Full Text] [Related]
34. Effect of PD fluid instillation on the peritonitis-induced influx and bacterial clearing capacity of peritoneal cells.
Hekking LH; Huijsmans A; Van Gelderop E; Wieslander AP; Havenith CE; van den Born J; Beelen RH
Nephrol Dial Transplant; 2001 Mar; 16(3):679-82; idscussion 683-5. PubMed ID: 11239068
[TBL] [Abstract][Full Text] [Related]
35. Membrane complement regulators protect against fibrin exudation increases in a severe peritoneal inflammation model in rats.
Mizuno M; Ito Y; Mizuno T; Harris CL; Suzuki Y; Okada N; Matsuo S; Morgan BP
Am J Physiol Renal Physiol; 2012 May; 302(10):F1245-51. PubMed ID: 22338087
[TBL] [Abstract][Full Text] [Related]
36. Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis.
Fusshoeller A
Pediatr Nephrol; 2008 Jan; 23(1):19-25. PubMed ID: 17638023
[TBL] [Abstract][Full Text] [Related]
37. Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis.
Bellón T; Martínez V; Lucendo B; del Peso G; Castro MJ; Aroeira LS; Rodríguez-Sanz A; Ossorio M; Sánchez-Villanueva R; Selgas R; Bajo MA
Nephrol Dial Transplant; 2011 Sep; 26(9):2995-3005. PubMed ID: 21324976
[TBL] [Abstract][Full Text] [Related]
38. Protein kinase C α inhibition prevents peritoneal damage in a mouse model of chronic peritoneal exposure to high-glucose dialysate.
Wang L; Balzer MS; Rong S; Menne J; von Vietinghoff S; Dong L; Gueler F; Jang MS; Xu G; Timrott K; Tkachuk S; Hiss M; Haller H; Shushakova N
Kidney Int; 2016 Jun; 89(6):1253-67. PubMed ID: 27142955
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis.
Dobbie JW
Perit Dial Int; 1992; 12(1):14-27. PubMed ID: 1347465
[TBL] [Abstract][Full Text] [Related]
40. [Peritoneum as a dialysis membrane. II. Pathology].
Grzybowski A; Breborowicz A
Przegl Lek; 1997; 54(1):52-61. PubMed ID: 9190636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
